Tyris Therapeutics has been awarded a grant by the AVI for the research of new therapies targeting hemorrhagic disorders

Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies

Tyris Therapeutics obtains financing support from the Digitaliza-CV program of the IVACE

AVI funding, obtained by Tyris Therapeutics, enables to validate the synthetic DNA to develop Gene Therapies